Relaxant Action of Plumula Nelumbinis Extract on Mouse Airway Smooth Muscle

The traditional herb Plumula Nelumbinis is widely used in the world because it has many biological activities, such as anti-inflammation, antioxidant, antihypertension, and butyrylcholinesterase inhibition. However, the action of Plumula Nelumbinis on airway smooth muscle (ASM) relaxation has not been investigated. A chloroform extract of Plumula Nelumbinis (CEPN) was prepared, which completely inhibited precontraction induced by high K+ in a concentration-dependent manner in mouse tracheal rings, but it had no effect on resting tension. CEPN also blocked voltage-dependent L-type Ca2+ channel- (VDCC-) mediated currents. In addition, ACh-induced precontraction was also completely blocked by CEPN and partially inhibited by nifedipine or pyrazole 3. Besides, CEPN partially reduced ACh-activated nonselective cation channel (NSCC) currents. Taken together, our data demonstrate that CEPN blocked VDCC and NSCC to inhibit Ca2+ influx, resulting in relaxation of precontracted ASM. This finding indicates that CEPN would be a candidate of new potent bronchodilators.


Introduction
Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent diseases that currently affect more than 300 million individuals worldwide. Excessive airway obstruction is a cardinal symptom in asthma and COPD [1][2][3]. Airway smooth muscle cells (ASMCs), one important cell type in the respiratory system, contribute to the symptoms of these airway obstructive diseases [4]. Excessive contraction of ASMCs can narrow the airway lumen, which limits gas exchange and threatens the lives of asthmatics and COPD patients [5,6]. Therefore, bronchodilators, such as 2 adrenergic agonists, are standard medicines that are widely used for the pharmacological management of these diseases [7,8].
However, the currently available bronchodilators have serious side effects; thus, the development of novel effective and safe bronchodilators is an important task for asthma and COPD therapy.
Some of traditional herbs have long been used in the treatment of asthma and COPD because they can effectively relax ASM contraction [9][10][11]. This inspired us to identify novel bronchodilators from the traditional herbs. This study investigated whether an extract of Plumula Nelumbinis relaxed precontracted ASM induced by high K + and ACh and the underlying mechanism.
The present study investigated the relaxation effects of a chloroform extract of Plumula Nelumbinis (CEPN) on mouse ASM precontraction induced by high K + and ACh. The results show that CEPN inhibited VDCCs and NSCCs, which then resulted in relaxation of precontracted ASM.  (1 Kg) were air-dried, milled into powder, and extracted at room temperature with 95% ethanol (3 × 4 L, 2 h each). Extracts were centrifuged, and the supernatants were collected. The ethanol extract (193 g) was next evaporated to dryness under reduced pressure using a rotary evaporator and immersed in a 2% HCl solution (500 mL). Residues were extracted with petroleum ether (3 × 300 mL, 4 h each) to remove lipids. Ammonia adjusted the pH of the filtrate to 10, and the crude sample was extracted with chloroform (5 × 300 mL, 4 h each). The chloroform extract was evaporated under reduced pressure, and the extraction yield was 0.71% of the raw material dry weight. The dried chloroform extract of Plumula Nelumbinis (CEPN) was dissolved in 3% DMSO for the experiments.

Animals.
Sexually mature male BALB/c mice were purchased from the Hubei Provincial Center for Disease Control and Prevention (Wuhan, China). Mice were housed at room temperature (20-25 ∘ C) and constant humidity (50-60%) under a 12 h light-dark cycle in an SPF grade laboratory. The animal study was performed according to the guidelines of the Institutional Animal Care and Use Committee of the South-Central University for Nationalities (Wuhan, China) and approved by the Animal Care and Ethics Committee of the South-Central University for Nationalities (QHL-2, 02-03-2012).

ASM Contraction Measurement.
Mouse ASM contraction was measured in tracheal rings [24,25]. Mice were sacrificed using an intraperitoneal injection of sodium pentobarbital (150 mg/kg), and tracheae were isolated and quickly transferred to ice cold PSS (composition in mM: NaCl 135, KCl 5, MgCl 2 1, CaCl 2 2, HEPES 10, glucose 10, pH 7.4). Connective tissues were removed, and small rings (∼5 mm) were cut from the bottom of tracheae. Each ring was mounted with a preload of 0.5 g in an organ bath with a 10 mL capacity containing PSS bubbled with 95% O 2 -5% CO 2 at 37 ∘ C. Tracheal rings were equilibrated for 60 min, precontracted with high K + (80 mM) or ACh (10 −4 M), washed, and rested 3 times. Experiments were performed following an additional 30 min rest.

Measurement of NSCC Currents.
The pipette solution contained the following chemicals for the measurement of NSCC currents (in mM): CsCl 18, cesium acetate 108, MgCl 2 1.2, HEPES 10, EGTA 3, CaCl 2 1, and pH 7.2 (adjusted with Tris). The free Ca 2+ concentration was approximately 70 nM, as calculated using WEBMAXC STANDARD. The bath solution was PSS without K + containing 10 M nifedipine, 100 M NA, and 10 mM TEA to block VDCC, Cl − , and K + currents, respectively. ACh-induced NSCC currents were recorded with a ramp using a perforated whole-cell configuration with a holding potential of −60 mV. The ramp was performed over 500 ms from −80 to +60 mV. 2.9. Statistical Analysis. Statistical analysis was performed with Student's -test using Origin 9.0 software (OriginLab, Northampton, USA). Statistical significance was defined as < 0.05. Data are expressed as the means ± SEM.

CEPN Inhibits High K + -Induced Precontraction.
We observed the effects of CEPN on high K + -induced ASM precontraction to investigate whether CEPN relaxed ASM. High K + (80 mM) induced contraction in a mouse tracheal ring, and CEPN (1 g-3.16 mg/mL) was cumulatively added to the organ bath. ASM contraction was gradually reduced to baseline (Figure 1(a)). CEPN was then removed and the high K + -induced contraction will restore to 26.7 ± 6.2% ( = 6) after 30 min. The results from 7 experiments yielded a half-maximal inhibition (IC 50 ) of 35.4 ± 1.4 g/mL and a maximal relaxation of 103.4 ± 1.3% (Figure 1(b)). It is well known that high K + induces depolarization resulting in the activation of VDCCs, which allows a Ca 2+ influx to trigger contraction [27,28]. This pathway was confirmed using a selective blocker of VDCCs, nifedipine (10 M), which completely blocked 80 mM K + -induced contractions (Figure 1(c)). CEPN inhibited precontraction, but it did not alter resting tension in 4 tracheal rings (Figure 1(d)). These data indicate that CEPN relaxed high K + -precontracted ASM via VDCC inhibition.
The above results suggest that the relaxation induced by CEPN might be due to the termination of VDCCmediated Ca 2+ influx. This hypothesis was examined in the following experiments. Figure 2(a) shows that high K + did not induce contraction under Ca 2+ -free conditions (0 mM Ca 2+ and 0.5 mM EGTA); however, contraction immediately occurred following Ca 2+ restoration (2 mM), and CEPN (1 mg/mL) completely inhibited contraction. However, a Ca 2+ restoration-induced contraction was not observed in the presence of 1 mg/mL CEPN (Figure 2(b)). This result suggests that CEPN-evoked relaxation of high K + -induced precontraction was completely dependent on the inhibition on VDCC-mediated Ca 2+ influx.

CEPN Blocks VDCC Currents.
We used patch-clamp techniques to measure VDCC currents (Ba 2+ as the carrier charge) [25] with voltage steps from −70 to +30 mV to further confirm the ability of CEPN to block VDCCs (Figures 3(a)  and 3(b)). Currents were abrogated following applications of CEPN and nifedipine. Current-voltage ( -) curves were constructed based on the results of 5 to 6 experiments (Figure 3(c)). These data indicate that CEPN blocked VDCCs.

CEPN Inhibits ACh-Induced Precontraction.
We next observed whether CEPN inhibited ACh-induced precontraction. Figure 4(a) shows that 1 mg/mL CEPN fully relaxed 100 M ACh-induced contraction (100.7 ± 0.4%, = 6). If CEPN was removed, the ACh-induced contraction will recover to 92.2 ± 3.4% ( = 7) within 30 min. Moreover, the precontraction was partially blocked following additions of nifedipine and the resistant component was totally inhibited by 1 mg/mL CEPN (Figure 4(b)). The maximal inhibition by nifedipine and CEPN was 52.1 ± 2.2%and 105.2 ± 2.0%, respectively ( = 6; Figures 4(b) and 4(c)). These results indicate that VDCCs and an unknown pathway mediate CEPN-induced relaxation of ACh-induced precontraction. Our data have showed that CEPN blocked VDCCs to induce relaxation of high K + -evoked precontraction. Therefore, we only focused on defining the unknown pathway. We first observed the role of the unknown pathway in the doseresponse of CEPN relaxation. Figure 4(d) shows that VDCCs were blocked with 10 M nifedipine, and ACh was added to induce a steady-state contraction. Contractions continuously declined to resting levels following cumulative additions of CEPN. The dose-response curve was constructed based on 6 experiments (Figure 4(e)). These data demonstrate that CEPN completely reduced ACh-induced precontraction through the inhibition of VDCCs and an unknown pathway.

CEPN Blocks ACh-Activated Ca 2+
Influx. Contraction is primarily dependent on the intracellular Ca 2+ increase [33,34]. Therefore, we investigated whether the unknown pathway involved Ca 2+ influx. ACh induced a transient contraction in the presence of nifedipine (10 M) and Ca 2+free conditions (0 mM Ca 2+ and 0.5 mM EGTA) ( Figure 6).
Addition of 2 mM Ca 2+ triggered a sustained contraction, which was blocked by 1 mg/mL CEPN. These results indicate that the steady-state contraction induced by ACh was due to a nifedipine-resistant Ca 2+ influx that was inhibited by CEPN. Therefore, the nifedipine-resistant Ca 2+ influx was defined as the unknown pathway.

CEPN Inhibits NSCCs.
We measured ACh-activated NSCC currents and observed the effects of CEPN on these currents to further determine the nature of the Ca 2+ influx because ACh activates NSCCs to increase intracellular Ca 2+ [25,35,36]. ACh-induced NSCC currents were purely isolated in the presence of nifedipine, NA and TEA, and were recorded by a ramp (Figure 7(a)). NSCC currents were partially blocked by CEPN (Figure 7(b)). Two representative ramp current traces at time points b and c (indicated in Figure 7(b)) are shown in Figure 7 at time point a (indicated in Figure 7(b)) were subtracted. The mean values of current amplitudes at −70 mV were −14.5 ± 0.5 pA and −7.8 ± 0.5 pA at time points b and c, respectively ( = 8, Figure 7(d)). These data indicate that CEPN partially inhibited ACh-induced NSCCs.

Discussion
The present study demonstrated that CEPN induced strong relaxation in precontracted mouse ASM induced by high K + and ACh through blockade of Ca 2+ influx mediated by VDCCs and NSCCs. This finding suggests that CEPN may be a potential bronchodilator.
High K + induces membrane depolarization, which opens VDCCs that mediate extracellular Ca 2+ influx and induce contractions [27,28]. The present study showed that CEPN completely inhibited high K + -induced contractions in ASM (Figures 1(a) and 1(b)), which suggests that this inhibition was due to the blockade of VDCCs by CEPN. We designed three different experiments to further support this result and showed that the selective blocker of VDCCs nifedipine totally inhibited high K + -evoked contractions (Figure 1(c)), CEPN inhibited Ca 2+ influx-induced contractions (Figure 2), and CEPN directly blocked VDCC-mediated currents (Figures  3(b) and 3(c)). These data demonstrate that CEPN blocked VDCCs, which terminated the Ca 2+ influx that leads to the relaxation of high K + -induced precontracted mouse ASM.
The muscarinic receptor agonist ACh activates both VDCCs and NSCCs, which leads to Ca 2+ influx and an increase in intracellular Ca 2+ to trigger ASM contraction [35,36]. This pathway was demonstrated in our recent results [25]. The present findings implied that CEPN-induced relaxation of ACh-evoked contraction (Figure 4(a)) resulted from the inhibition of both VDCCs and NSCCs by CEPN. This is because the fact that (1) CEPN completely blocked AChinduced contraction (Figure 4(a)), (2) the selective blocker of VDCCs, nifedipine, partially inhibited ACh-induced contraction and the remaining component was blocked by CEPN ( Figures 4(b), 4(c), 4(d), and 4(e)), and the latter was due to the inhibition of Ca 2+ influx by CEPN ( Figure 6), (3) ACh-induced NSCC currents, which mediate Ca 2+ influx, were partially blocked by CEPN (Figure 7), and (4) AChinduced contraction was partially blocked by Pyr3, a selective blocker of nonselective cation channel TRPC3 and Orai ( Figure 5). Therefore, we conclude that CEPN blocks VDCCand NSCC-mediated Ca 2+ influx to result in relaxation of ACh-precontracted ASM.

Conclusions
CEPN induced relaxation of precontracted mouse ASM through the inactivation of VDCCs and NSCCs. This study supports the development of new drugs from CEPN to treat airway hyperresponsiveness in asthmatic and COPD patients. Further investigation will be required to identify the components that are responsible for the relaxation action.